HPLC purity is the most-cited and least-understood number on a peptide Certificate of Analysis. Here is what the percentage actually measures — and what it does not.
The One-Sentence Definition
A peptide’s “HPLC purity” is the percentage of total chromatographic peak area attributable to the target peptide, measured on a reverse-phase analytical HPLC column under specified conditions (mobile phase, gradient, wavelength).
It is not a measure of mass, not a measure of concentration, and not a measure of biological activity. It is a measure of chemical homogeneity as detected by UV absorbance at — typically — 220 nm.
How the Number Is Generated
A qualified peptide reference lab runs a small amount of the purified material (typically 5–20 µg) on a C18 or C4 column. A UV detector at 220 nm (where the peptide backbone amide absorbs) integrates the area under each peak in the elution profile. The integration is normalized — the target peak divided by total peak area, multiplied by 100.
If the target peak is 99.4% of total area, the reported HPLC purity is 99.4%. If there are three visible impurity peaks at 0.2%, 0.2%, and 0.2% along with the main peak, the purity is 99.4%.
What ≥ 99% Really Means
A ≥ 99% HPLC purity figure indicates that < 1% of the observable chromatographic area is non-target material. For a peptide reference standard, this threshold is the minimum acceptable bar; many chemistry applications (receptor-binding assays, analytical-method development, comparative structural studies) require this level for reproducibility.
What ≥ 99% does not tell you:
- Whether the counterion (usually TFA or acetate) content is quantified — this affects actual peptide mass per milligram.
- Whether the molecular identity is correct — that’s a mass-spec question.
- Whether the peptide is biologically active — that’s a bioassay question.
- Whether bacterial endotoxins are below research-relevant levels — that’s an LAL question.
The Four Measurements a Full COA Shows
- HPLC purity — answers: “Is this chemically homogeneous?”
- Mass spectrometry (ESI-MS or MALDI-TOF) — answers: “Is this the right molecule?”
- Endotoxin (LAL) — answers: “Is it free of bacterial contaminants?”
- Moisture (Karl Fischer) — answers: “Is the lyophilized cake actually dry?”
When any of these are missing, the “COA” is incomplete. Every BioFusion Aminos COA reports all four per lot.
Column and Gradient Disclosure — The Hidden Variable
A less-discussed variable: HPLC purity depends on how hard the method is designed to resolve impurities. Two labs running the same peptide on:
- A short, low-resolution C18 method with a steep gradient, or
- A long, slow-gradient method on a high-efficiency stationary phase
…will get different purity numbers. The slow method will reveal closely-eluting impurities that the fast method co-elutes into the main peak.
A credible reference standard COA discloses the method, not just the number. Look for: column, mobile phase, gradient, flow rate, detection wavelength, and injection volume.
Worked Example: BPC-157
A BPC-157 lyophilized reference standard passing release will typically show:
- C18 column, 150 × 4.6 mm, 5 µm particle
- Mobile phase A: 0.1% TFA in water; B: 0.1% TFA in acetonitrile
- Gradient: 5% → 65% B over 30 min
- Detection at 220 nm, 20 µL injection
- Target peak at ~14 min; total area > 99%
The Takeaway
“≥ 99% HPLC purity” on a Certificate of Analysis is a necessary but not sufficient indicator of reference-standard quality. Pair it with MS, endotoxin, and moisture — and verify the method disclosure — before trusting the number for research chemistry.
Related Reading
- How to Read a Peptide Certificate of Analysis
- Fmoc vs Boc Synthesis Explained
- Choosing a U.S. Peptide Supplier: Research Checklist
Laboratory research use only. Not for human or veterinary consumption.